mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.07 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.07 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.08 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.08 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.08 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.08 |
mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.09 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.09 |